Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery

NCT07289685 | Completed

• 2 other identifiers: 202102412B0CMRPG3M2171
• Study Type: observational
• Target: 192
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement. Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs. Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care. The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (1)

• Hospital Length of Stay

  The number of calendar days from the date of colorectal surgery to the date of hospital discharge, recorded from the hospital electronic medical record.

  Through hospital discharge (an average of 7 days after surgery)

Secondary Outcomes (1)

• Postoperative Complications (Clavien-Dindo classification)

  Postoperative Day 30

Study Arms (1)

Postoperative Colorectal Cancer Patients with Wearable Device Monitoring

Patients diagnosed with colorectal cancer who underwent minimally invasive surgery. Participants wore a wrist-worn device to monitor postoperative physical activity, heart rate, and sleep for up to 7 days or until discharge.

Eligibility Criteria

• Age: 20 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults aged 20 to 85 years diagnosed with colorectal cancer who underwent minimally invasive surgery at a medical center. Patients must be able to communicate in Mandarin or Taiwanese and provide informed consent.

You may qualify if:

• Patients undergoing minimally invasive colorectal tumor resection.
• Aged 20 to 85 years.
• ECOG score 0-2.
• Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
• Informed consent provided by the patient or family.

You may not qualify if:

• Patients with acute/chronic psychiatric disorders or cognitive impairment.
• Patients undergoing traditional open or local resection surgeries.

Sponsors & Collaborators

• Chang Gung Memorial Hospital: lead

Study Sites (1)

Chang Gung Memorial Hospital, Linkou

Taoyuan District, 333, Taiwan

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 20, 2025
• First Posted: December 17, 2025
• Study Start: August 8, 2022
• Primary Completion: January 5, 2024
• Study Completion: January 8, 2024
• Last Updated: December 17, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)